Pasithea Therapeutics Corp.
(NASDAQ:KTTA)
$0.30
0.00 (0.00%)
Open: 12:39 PM
KTTA Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
KTTA Stock Price Today
Pasithea Therapeutics Corp. (KTTA) stock rallied over 5.17% intraday to trade at $0.305 a share on NASDAQ. The stock opened with a gain of 13.64% at $0.38 and touched an intraday high of $0.38, falling -7.58% against the last close of $0.33. The Pasithea Therapeutics Corp. in stock market went to a low of $0.33 during the session.
KTTA Stock Snapshot
$0.33
Prev. Close
6.25 Million
Market Cap
$0.33
Day Low
$0.38
Open
26.04 Million
Number of Shares
$0.38
Day High
N/A
P/E ratio
-0.62
EPS (TTM)
0.94
Cash Flow per Share
N/A
Free Float in %
1.36
Book Value
8322.00
Volume
KTTA Stock Price History Chart
Date | Open | High | Low | Close | Volume |
---|
Contact Details
Company Information
Employees15.00
Beta0.71
Sales or Revenue$486.56 Thousands
5Y Sales Change1565.19%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Peers
Frequently Asked Questions
What is the current Pasithea Therapeutics Corp. (KTTA) stock price?
Pasithea Therapeutics Corp. (NASDAQ: KTTA) stock price is $0.30 in the last trading session. During the trading session, KTTA stock reached the peak price of $0.38 while $0.33 was the lowest point it dropped to. The percentage change in KTTA stock occurred in the recent session was 5.17% while the dollar amount for the price change in KTTA stock was $0.02.
KTTA's industry and sector of operation?
The NASDAQ listed KTTA is part of Biotechnology industry that operates in the broader Healthcare sector. Pasithea Therapeutics Corp. , a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders.
Who are the executives of KTTA?
Dr. Tiago Reis Marques M.D., Ph.D.
Chief Executive Officer & Director
Dr. Yassine Bendiabdallah Ph.D.
Chief Operating Officer & Head of UK Clinics
Dr. Lawrence Steinman BA, M.D., Ph.D.
Exec. Chairman & Co-Founder
Dr. Graeme Currie Ph.D.
Chief Devel. Officer
How KTTA did perform over past 52-week?
KTTA's closing price is 0.00% lower than its 52-week low of $0.31 where as its distance from 52-week high of $1.1 is -0.80%.
How many employees does KTTA have?
Number of KTTA employees currently stands at 15.00. KTTA operates from 1111 Lincoln Road, Miami Beach, FL 33139, US.
Link for KTTA official website?
Official Website of KTTA is: https://www.pasithea.com
How do I contact KTTA?
KTTA could be contacted at phone #702 514 4174 and can also be accessed through its website. KTTA operates from 1111 Lincoln Road, Miami Beach, FL 33139, US.
How many shares of KTTA are traded daily?
KTTA stock volume for the day was 8322.00 shares. The average number of KTTA shares traded daily for last 3 months was 41.13 Thousands.
What is the market cap of KTTA currently?
The market value of KTTA currently stands at $6.25 Million with its latest stock price at $0.30 and 26.04 Million of its shares outstanding.